NVST - Envista Holdings - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29415F1049
Dental Implants, Orthodontic Products, Dental Equipment, Imaging Systems, Consumables
Envista Holdings Corporation is a leading dental products company that designs, manufactures, markets, and sells a wide range of dental solutions to oral care professionals worldwide. With a strong presence in the United States, China, and international markets, the company operates through two main segments: Specialty Products & Technologies, and Equipment & Consumables.
The Specialty Products & Technologies segment focuses on providing innovative solutions to oral surgeons, prosthodontists, periodontists, and general dentists. Its product portfolio includes dental implant systems, guided surgery systems, biomaterials, and custom-built prosthetics. Additionally, the segment offers orthodontic laboratory products, such as brackets and wires, tubes and bands, archwires, clear aligners, and digital orthodontic treatments. To support these products, the company provides software packages, including DTX Studio Implant, DTX Studio Lab, and DTX Studio Clinic, which are designed to enhance the efficiency and accuracy of dental procedures. Envista's products in this segment are marketed under well-known brands, including Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, and AOA.
The Equipment & Consumables segment is dedicated to providing dental offices, clinics, and hospitals with a comprehensive range of dental equipment and supplies. This includes digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. The segment's products are marketed under brands such as Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes.
Headquartered in Brea, California, Envista Holdings Corporation was founded in 2018 and has since become a prominent player in the global dental industry. For more information, visit their website at https://envistaco.com.
Drawdown (Underwater) Chart
NVST Stock Overview
Market Cap in USD | 3,043m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC SubIndustry | Health Care Equipment |
TER | 0.00% |
IPO / Inception | 2019-09-18 |
NVST Stock Ratings
Growth 5y | -45.0 |
Fundamental | -36.1 |
Dividend | |
Rel. Performance vs Sector | -3.37 |
Analysts | 3.50/5 |
Fair Price Momentum | 18.21 USD |
Fair Price DCF | 41.57 USD |
NVST Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
NVST Growth Ratios
Growth Correlation 3m | 61.8% |
Growth Correlation 12m | -81.5% |
Growth Correlation 5y | -21% |
CAGR 5y | -8.09% |
CAGR/Mean DD 5y | -0.29 |
Sharpe Ratio 12m | -0.45 |
Alpha vs SP500 12m | -74.90 |
Beta vs SP500 5y weekly | 1.43 |
ValueRay RSI | 89.09 |
Volatility GJR Garch 1y | 34.82% |
Price / SMA 50 | 4% |
Price / SMA 200 | -0.47% |
Current Volume | 2288k |
Average Volume 20d | 1879.6k |
External Links for NVST Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of October 29, 2024, the stock is trading at USD 19.23 with a total of 2,288,003 shares traded.
Over the past week, the price has changed by +3.55%, over one month by -2.68%, over three months by +17.11% and over the past year by -17.36%.
According to ValueRays Forecast Model, NVST Envista Holdings will be worth about 20 in October 2025. The stock is currently trading at 19.23. This means that the stock has a potential upside of +4%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 18.6 | -3.28 |
Analysts Target Price | 40.7 | 111 |
ValueRay Target Price | 20 | 4.00 |